Home
Kymera Therapeutics Inc

Kymera Therapeutics Inc Market Share Analysis for November 2025

Kymera is a clinical stage biopharmaceutical company focused on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Stock Information. KYMR. Jul 17, 2024. $47.20.

Health > Biotechnology and Pharmaceuticals

Domainkymeratx.com

Year Founded2015

Employees51 - 200

Annual Revenue$25M - $50M

Kymera Therapeutics Inc

Kymera Therapeutics Inc (including company regionals)

kymeratx.com

See more website traffic and engagement information

Kymera Therapeutics Inc Revenue up to November 2025 is 25M - 50M

revenue generated by Kymera Therapeutics Inc top domains

Kymera Therapeutics Inc top domains revenue over 3 years

Revenue for Kymera Therapeutics Inc top domains

kymeratx.com25M - 50M

See more with Sales Intelligence

Kymera Therapeutics Inc Stock price in November 2025

Kymera Therapeutics Inc stock is traded under the ticker #KYMR. Below you can review Kymera Therapeutics Inc stock performance in the past 12 months up to November 2025

Total visits to Kymera Therapeutics Inc's top domains

Understand Kymera Therapeutics Inc market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

kymeratx.com18.2K

See more with Sales Intelligence

Avg. visit duration in Kymera Therapeutics Inc's top domains

Analyze Kymera Therapeutics Inc engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

kymeratx.com00:01:38

See more with Sales Intelligence

Avg. pageviews on Kymera Therapeutics Inc's top domains

See how Kymera Therapeutics Inc keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

kymeratx.com2.52

See more with Sales Intelligence

Kymera Therapeutics Inc top competitors by domain

Top similar sites in November 2025, ranked by their affinity

ornatx.comCompany NameOrna TherapeuticsEmployees51 - 200HQUnited States, Massachusetts, WatertownAnnual revenue$25M - $50MTotal visits3.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Kymera Therapeutics Inc

These are the website technologies, by industry, used by Kymera Therapeutics Inc top domains

Payment & Currencies (8)

Cart Functionality

Widget (5)

Twemoji

Conversion & Analytics (4)

Google Analytics

Advertising (3)

Google Adsense

More Technologies

13

See all

News & Signals from Kymera Therapeutics Inc

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsKymera Therapeutics, Inc. attends event American College of Rheumatology Annual Meeting.Kymera Therapeutics presents new preclinical data for KT-579, a first-in-class, Oral IRF5 Degrader, at the American College of Rheumatology Annual Meeting.

NewsKymera Therapeutics, Inc. hires Brian Adams as Chief Legal Officer.Brian Adams has been appointed as Kymera Therapeutics' Chief Legal Officer (CLO) and Corporate Secretary.

NewsKymera Therapeutics, Inc. is developing TPD drugs.Kymera Therapeutics Inc. (NASDAQ:KYMR) is developing oral TPD drugs that could provide greater accessibility and convenience as compared to injectable options.